Integrative Analysis of Deep Sequencing Data Identifies Estrogen Receptor Early Response Genes and Links ATAD3B to Poor Survival in Breast Cancer

PLoS Computational Biology

Volumn 9, Issue 6, 2013, Pages

  Ovaska, Kristian ^a   Matarese, Filomena ^b   Grote, Korbinian ^c   Charapitsa, Iryna ^d   Cervera, Alejandra ^a   Liu, Chengyu ^a   Reid, George ^d   Seifert, Martin ^c   Stunnenberg, Hendrik G ^b   Hautaniemi, Sampsa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Genomatix GmbH   (Germany)

^d Institute of Molecular Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; DISEASES; TRANSCRIPTION;

BINDING-SITES; BIOLOGICAL PROCESS; BREAST CANCER; CELLULARS; DYNAMIC LEVELS; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR Α; INTEGRATIVE ANALYSIS; MULTILEVELS; TRANSCRIPTION START SITE;

BINDING SITES;

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HISTONE H2AZ; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE; RNA POLYMERASE II;

AGED; ARTICLE; ATAD3B GENE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EARLY RESPONSE GENE; FEMALE; GENE; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN BINDING; TRANSCRIPTION INITIATION SITE;

EID: 84879524072     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003100     Document Type: Article

References (38)

1. Ochsner S, Steffen D, Hilsenbeck S, Chen E, Watkins C, et al. (2009) GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17β-estradiol in MCF-7 cells. Cancer Research 69: 23.
2. Welboren W, Van Driel M, Janssen-Megens E, Van Heeringen S, Sweep F, et al. (2009) ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligands. The EMBO Journal 28: 1418-1428.
3. Ross-Innes C, Stark R, Teschendorff A, Holmes K, Ali H, et al. (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481: 389-393.
4. Selth L, Sigurdsson S, Svejstrup J, (2010) Transcript elongation by RNA polymerase II. Annual Review of Biochemistry 79: 271-293.
5. Tippmann SC, Ivanek R, Gaidatzis D, Schöler A, Hoerner L, et al. (2012) Chromatin measurements reveal contributions of synthesis and decay to steady-state mRNA levels. Molecular Systems Biology 8: 593.
6. Nielsen R, Pedersen T, Hagenbeek D, Moulos P, Siersbæk R, et al. (2008) Genome-wide profiling of PPAR: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes & Development 22: 2953-2967.
7. Core L, Waterfall J, Lis J, (2008) Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322: 1845.
8. Lupien M, Meyer C, Bailey S, Eeckhoute J, Cook J, et al. (2010) Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance. Genes & Development 24: 2219-2227.
9. The Cancer Genome Atlas Network, (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
10. Sun H, Wu J, Wickramasinghe P, Pal S, Gupta R, et al. (2011) Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seq. Nucleic Acids Research 39: 190.
11. Pal S, Gupta R, Kim H, Wickramasinghe P, Baubet V, et al. (2011) Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development. Genome Research 21: 1260-1272.
12. Raisner R, Hartley P, Meneghini M, Bao M, Liu C, et al. (2005) Histone variant H2A.Z marks the 5′ ends of both active and inactive genes in euchromatin. Cell 123: 233-248.
13. Flicek P, Amode M, Barrell D, Beal K, Brent S, et al. (2012) Ensembl 2012. Nucleic Acids Research 40: D84-D90.
14. Johnston S, (2010) New strategies in Estrogen Receptor-positive breast cancer. Clinical Cancer Research 16: 1979-1987.
15. Beelen K, Zwart W, Linn S, (2012) Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? Nature Reviews Clinical Oncology 9: 529-541.
16. Li S, Rousseau D, (2012) ATAD3, a vital membrane bound mitochondrial ATPase involved in tumor progression. Journal of Bioenergetics and Biomembranes 44: 189-197.
17. Hager G, McNally J, Misteli T, (2009) Transcription dynamics. Molecular Cell 35: 741-753.
18. Maiuri P, Knezevich A, De Marco A, Mazza D, Kula A, et al. (2011) Fast transcription rates of RNA polymerase II in human cells. EMBO reports 12: 1280-1285.
19. Churchman L, Weissman J, (2011) Nascent transcript sequencing visualizes transcription at nucleotide resolution. Nature 469: 368-373.
20. Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biology 9: R137.
21. Qin Z, Yu J, Shen J, Maher C, Hu M, et al. (2010) HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data. BMC Bioinformatics 11: 369.
22. Rozowsky J, Euskirchen G, Auerbach R, Zhang Z, Gibson T, et al. (2009) PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nature Biotechnology 27: 66-75.
23. Suman B, Kumar P, (2005) A survey of simulated annealing as a tool for single and multiobjective optimization. Journal of the Operational Research Society 57: 1143-1160.
24. Hah N, Danko C, Core L, Waterfall J, Siepel A, et al. (2011) A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145: 622-634.
25. Sengupta S, Sharma C, Jordan V, (2010) Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells. Hormone Molecular Biology and Clinical Investigation 2: 235-243.
26. Tang S, Han H, Bajic VB, (2004) ERGDB: estrogen responsive genes database. Nucleic Acids Research 32: D533-D536.
27. Jin V, Sun H, Pohar T, Liyanarachchi S, Palaniswamy S, et al. (2005) ERTargetDB: an integral information resource of transcription regulation of estrogen receptor target genes. Journal of Molecular Endocrinology 35: 225-230.
28. Cicatiello L, Mutarelli M, Grober O, Paris O, Ferraro L, et al. (2010) Estrogen receptor α controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. The American Journal of Pathology 176: 2113-2130.
29. Yager J, Davidson N, (2006) Estrogen carcinogenesis in breast cancer. New England Journal of Medicine 354: 270-282.
30. Miller L, Smeds J, George J, Vega V, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proceedings of the National Academy of Sciences 102: 13550-13555.
31. Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Research 7: R953.
32. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, et al. (2010) Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Medicine 2: 65.
33. Mukherjee S, Mitra S, (2005) Hidden Markov Models, grammars, and biology: a tutorial. Journal of Bioinformatics and Computational Biology 3: 491.
34. Ross T (2010) Fuzzy logic with engineering applications, third edition. John Wiley & Sons.
35. Ouyang Z, Zhou Q, Wong WH, (2009) ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proceedings of the National Academy of Sciences 106: 21521-21526.
36. Tavassoli FA, Devilee P (2003) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization.
37. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
38. Robinson J, Thorvaldsdóttir H, Winckler W, Guttman M, Lander E, et al. (2011) Integrative genomics viewer. Nature Biotechnology 29: 24-26.